Abstract
Introduction
Nosocomial infections caused by Pseudomonas aeruginosa producing carbapenemases are being reported ever more frequently worldwide, and they represent an important cause of morbidity and mortality among immunosuppressed patients (1) (2) (3) . Most carbapenem resistance is due to impermeability by the loss of the OprD porin, but carbapenem-hydrolizing metallo-β-lactamases (MBLs) are increasingly reported (4) 
2+
) as co-factors in their catalytic action on the β-lactam ring of carbapenems (3, (5) (6) (7) . Group A includes penicillinases, extended-spectrum beta-lactamases (ESBL) and class A carbapenemases. Klebsiella pneumoniae carbapenemases (KPCs) belongs to this group, which hydrolyze penicillins, cephalosporins and carbapenems. These enzymes are inhibited or partially inhibited by clavulanate or tazobactam (5) . KPC-producing P. aeruginosa isolates were first reported in 2006 from Colombia and subsequently in Puerto Rico, in Trinidad and Tobago, in the southern part of the United States, and in China (8) . Group C includes AmpC cephalosporinases, which exhibits a greater hydrolysis for cephalosporins in comparison to benzylpenicillin (5, 6) . Group D includes oxacillinases (OXAs), enzymes able to hydrolyze cloxacillin or oxacillin. Some of them can hydrolyse carbapenems, such as OXA-48 or OXA-23 (5, 9) . MBLs are the most important carbapenemases class both due to their ability to hydrolyse all β-lactams drugs, with the exception of monobactams (3, 4) , and also due to their resistance to inhibitors (10) . At present, group B of MBLs are divided into three subclasses (B1, B2 and B3) (11) . The most common MBLs reported worldwide belong to the subclass B1, being represented by different families: IMP, VIM, SPM, SIM, GIM, NDM, DIM (11) . The most prevalent families of MBLs are the IMP and VIM enzymes; 53 IMP subtypes and 46 VIM variants are known, grouped into 3 clusters (11-13). IMP-type MBL determinants are mostly found in P. aeruginosa, Acinetobacter baumannii and Enterobacteriaceae strains (12) . VIM enzymes are prevalent in Europe, although they are currently widespread on all 5 continents, especially VIM-2 (14) . VIM-2 has been shown to be associated with a gene cassette, which encodes enzymes that inactivate aminoglycosides (15).
In 2014, the level of carbapenem resistance in P. aeruginosa strains isolated from our hospital reached an average value of 66.9%, which led us to initiate this study for MBLs detection.
The aim of the present study was to detect the production of carbapenemases in P. aeruginosa strains by phenotypic methods (double disk synergy test, E-test) and the presence of the most common MBLs encoding genes (bla VIM, bla IMP ) by polymerization chain reaction (PCR).
Materials and methods
We conducted a prospective study between September 2014 -February 2015 in the microbiology department of the Regional Institute of Gastroenterology and Hepatology (RIGH), Cluj-Napoca, Romania. In this study, a total of 38 non-repeat P. aeruginosa strains, with resistance to carbapenems isolated from the hospitalized patients during this period, were included. We obtained the agreement of the Ethics Committee for this study.
The P. aeruginosa strains were identified using the VITEK Further studies were performed on all 38 non-susceptible of P. aeruginosa strains to carbapenems (MICimipenem ≥16 μg/ ml, MICmeropenem ≥16 μg/ml). The carbapenemase production was confirmed by plating the strains on chromID ® CARBA (BioMérieux, France). For all carbapenemase-producing strains, the antimicrobial susceptibility to aztreonam (ATM) was tested by Kirby-Bauer method with ATM 30 µg disk (Oxoid, UK). The interpretation was performed according to CLSI 2014 standards (16).
I. The phenotypic detection of MBLs production was done by:
I.a. double disk synergy test (DDST) using the KPC/MBL in P. aeruginosa/Acinetobacter baumannii confirmation kit (ROSCO ® Diagnostics, Taastrup, Denmark). An overnight broth culture from the tested strains (turbidity adjust-ed to 0.5 McFarland standard) was inoculated on a Mac Conkey agar plate in accordance to the manufacturer's rules. Then, five disks: IMI-10 µg (imipenem), MRP-10 µg (meropenem), DPA (dipicolinic acid), MRPBO (meropenem combined with phenylboronic acid -PBO) and MPCXH (meropenem combined with high concentration of cloxacillin -CXH) were applied on the agar plate. The plate was incubated at 37ºC for 18±2 hours (overnight) (17) . Internal quality control was performed with the control strains: P. aeruginosa ATTC 10145/CCUG 59626, MBL positive and K. pneumoniae CCUG 56233, KPC positive ( Table 1) .
I.b. MBL E-test (Epsilometer -test) was performed with the Etest
® MBL IP/IPI 256/64 (BioMérieux, Marcy-l'Étoile, France), IP (imipenem) (4-256 μg/ml) / IPI (imipenem: 1-64 μg/ml + ethylenediaminetetraacetic acid -EDTA -at a constant level) (18) .
Interpretation: MBL positive: a reduction in the minimum inhibitory concentration (MIC) in the presence of EDTA greater than or equal to eight (IP/IPI ≥8); the deformation of the ellipse or the presence of a phantom-zone (18) .
II. The genotypic detection of MBL production was done by PCR method for genes: blaIMP, blaVIM.
Fresh cultures were harvested and boiled in buffer TBE (Tris Borat EDTA) for 15 minutes, and briefly centrifuged (13,000 rpm, 2 min). Supernatants were used as PCR templates. The following primers were synthesized (at Eurogentec, Belgium) and used. The selected primers for the genes that codify the MBLs had been chosen as general primers for the IMP and VIM MRP 10 -meropenem dsk; IMI 10 -imipenem disk; MRPBO -meropenem disk combined with phenylboronic acid; MPCXH -meropenem disk combined with cloxacillin high; DPAdipicolinic acid; KPC -Klebsiella pneumoniae carbapenemase; MBLs -metallo-β-lactamases. Electrophoresis was carried out on 1.8% agarose gel. The molecular tests for blaIMP and blaVIM were separately done (mono PCR). The tests were performed in duplicate and the results were similar. We used two strains as internal positive control, one positive for blaIMP, and the other one, positive for blaVIM, confirmed in another center ( Table 2) .
Statistical analysis
The analysis of concordance between phenotypic screening methods (ROSCO ® and E-test) and PCR, considered the reference method, we applied the Mc'Nemar test, Cohen's Kappa coefficient. Fisher's exact test was used for testing the association between the ATM variable and studied tests (ROSCO ® and E-test). For all two-sided tests, we considered that statistical significance was achieved when the estimated p-value was <0.05. Data were analyzed using IBM SPSS Statistics v.20 (Armonk, NY: IBM Corp.).
Results
The thirty-eight tested strains were isolated from surgery (n=21; 55.3%), intensive care unit -ICU (n=6; 15.8%), and gastroenterology wards (n=11; 28.9%). These strains were isolated from various clinical specimens: pus (n=9; 23.7%), tracheal secretion (n=5; 13.2%), bile (n=7; 18.4%), sputum (n=6; 15.8%), blood (n=3; 7.9%), central venous catheters (n=2; 5.3%), urine (n=2; 5.3%), nasal secretion (n=1; 2.6%), stool (n=1; 2.6%) and other secretions (n=2; 5.3%).
The tested P. aeruginosa strains had significant resistance to multiple classes of antibiotics (anti-pseudomonal β-lactams, aminoglycosides, fluoroquinolones). See figure 1. Only one strain (2.6%) showed resistance to polypeptides (MICcolistin: 4 mg/l). To ATM, 18/38 strains (56.5%) were susceptible, 8/38 intermediate (21.1%), and 12/38 (31.6%) were resistant. All these strains grew on chromID ® CARBA (Figure 1) . The phenotypic detection of carbapenemases production:
I.a. Phenotypic detection of MBL with the ROSCO ® method: The synergy area was observed between IMI ± DPA disks in twenty-eight strains (73.7%), ten strains (26.3%) were MBL negative. For MRP, the synergy area was obvious in twenty-two strains (57.9%) and absent in sixteen strains (42.1%). Eleven strains were positive for KPC (28.9%), twenty-seven strains were negative for KPC (71.1%).
I.b. MBL IP/IPI E-test:
Twenty-eight strains (73.7%) were MBL+ for a ratio IP/IPI ≥8 and the rest were negative.
II. Genotypic detection of genes encoding MBLs (blaIMP, blaVIM) by PCR method:
12 strains out of 38 tested strains (34,2%) carried one or both genes -6 (15.8%) strains were blaIMP+, 2 (5.3%) strains were blaVIM+ and 4 (10.5%) strains were blaIMP+/blaVIM+. Two blaIMP+ and one blaVIM+ strains were isolated from ICU, 2 blaIMP+, one blaVIM+ and 2 blaIMP+/blaVIM+ strains were isolated from surgery. Two blaIMP+, one blaVIM+ strain and one blaIMP+/blaVIM+ were isolated from gastroenterology wards.
The blaIMP+ strains were isolated from sputum, tracheal secretion, nasal secretion, pus, blood, and central venous catheters, the blaVIM+ strains from urine and sputum, and the blaIMP+/blaVIM+ strains from tracheal secretion, pus and other secretions. These pathological specimens were related to several medical devices (intravenous or urinary catheters, tubes, cannulae, assisted ventilation appliances), on which P. aeruginosa has the ability to attach and multiply, forming an impossible to remove bio-film.
These strains showed a very high level of resistance to all anti-pseudomonal β-lactams. All the blaIMP and blaVIM positive strains (12/38) were resistant to ticarcillin (TIC), ticarcillin combined with clavulanat (TIM), piperacillin (PIP) and piperacillin combined with tazobactam (TPZ), ceftazidime (CAZ) and cefepime (FEP). (Table 3) .
Regarding the association between the two phenotypic tests, there was concordance between their results. ® /E-test negative which was susceptible to CAZ, but resistant to TIC, TIM, TPZ, FEP could suffer a mutation that causes Mex-EF-OprN hyperproduction combined with OprD downregulation, a mechanism more rarely seen, which primarily affects fluoroquinolones (20) . MBLs hydrolyse all β-lactams, except monobactams, whose representative is ATM (23) . ATM is considered 2nd therapeutic option (after colistin) (23) among active agents against MBLs+ P. aeruginosa strains. All the blaIMP+ and blaVIM+ strains were susceptible to ATM. We have not found significant statistical association between sensitivity to ATM and the ROSCO ® method. Likewise we have not found significant statistical association between sensitivity to ATM and the E-test. This could be explained by the existence of other MBLs (unexplored by us), or association with other mechanisms: production of ESBL or KPCs (23), hyper-production of a chromosomal AmpC (4), or the synthesis of carbapenemases class D (OXA-23, OXA-24, OXA-58, OXA-48, OXA-181) (21). In our study, the blaIMP+ strains were sensitive to amikacin, resistant to gentamicin and had variable sensitivity to tobramycin while all the blaVIM+ strains were resistant to aminoglycosides. It is known that the blaVIM gene is associated to class 1 integrons with one or more genes for resistance to aminoglycosides, being able to inactivate antipseudomonal aminoglycosides (gentamicin, tobramycin, amikacin) (24) . All the blaVIM+ strains were resistant to ciprofloxacin while 2 out of 4 blaIMP+ strains were susceptible to ciprofloxacin. It could be explained by presence of multiple mechanisms of resistance, such as the MBL synthesis associated with the expression of efflux pumps MexAB-OprM or MexXY, responsible for associated resistance to fluoroquinolones (20) . It is possible that a strain produces more types of carbapenemases. We have detected four positive strains for blaIMP and blaVIM genes. M. Wang et al. reported a strain of P. aeruginosa producing multiple carbapenemases: NDM-1, VIM-5, VIM-6 (25).
There were important differences between the molecular and phenotypic tests. These could be explained by the secretion of other MBLs, which were not tested in our study. Several Romanian studies regarding MBLs in P. aeruginosa strains were made in the last years. In a study conducted in Cluj-Napoca, between 2008-2009, Craciunas et al have not detected blaIMP and blaVIM genes in P. aeruginosa strains but OXA-50 and OXA-2 genes, responsible for multidrug resistance of tested strains, were detected (28 
Conclusions
This was the first study performed in our hospital regarding testing blaIMP and blaVIM genes to carbapenem-resistant strains of P. aeruginosa. 6 blaIMP+, 2 blaVIM+ were detected and 4 strains were secreted both MBLs blaIMP+/blaVIM+ strains. We showed the presence of blaIMP gene in this part of Romania. The phenotypic methods for screening MBLs were useful for diagnosis. In further studies, we intend to investigate a wider field of genes to follow the genetic resistance profile of the circulating P. aeruginosa strains in our hospital. 
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